CEO Interview
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Developing and commercializing active ingredients from natural sources for healthcare and personal care industries.
Learn More about our ProductsPGX technology is a novel spray drying technique for processing water-soluble biopolymers which utilizes the unique and tunable properties of Pressurized Gas eXpanded liquids.
Learn More About PGXTSX Venture
CZO
Change
Volume
Day Range
52 Week Range
OTCQX Markets
CRPOF
Change
Volume
Day Range
52 Week Range
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
View our latest corporate presentation to learn more about Ceapro, our products and our proprietary manufacturing technology.
View PresentationCeapro isolates ingredients from oat products, such as Avenanthramides and Beta Glucan, and botanical products to naturally enhance popular cosmetic and personal care products.
View Our Products
Ceapro Inc. Announces Issuance of U.S. and European Patent for Flagship Product, Avenanthramides
Oct 29, 2019 | Read More
Ceapro Begins Trading on the OTCQX Best Market
Oct 16, 2019 | Read More
OTC Markets Group Welcomes Ceapro Inc. to OTCQX
Oct 16, 2019 | Read More
Ceapro to Present PGX Technology at the 3rd International Symposium on Pharmaceutical Engineering Research
Sep 25, 2019 | Read More